BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24121191)

  • 1. Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.
    Miller T; Goude MC; McDevitt TC; Temenoff JS
    Acta Biomater; 2014 Apr; 10(4):1705-19. PubMed ID: 24121191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.
    Adage T; Piccinini AM; Falsone A; Trinker M; Robinson J; Gesslbauer B; Kungl AJ
    Br J Pharmacol; 2012 Nov; 167(6):1195-205. PubMed ID: 22747966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Modification of Glycosaminoglycan Polysaccharides.
    Palhares LCGF; London JA; Kozlowski AM; Esposito E; Chavante SF; Ni M; Yates EA
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Dynamics Approaches Dissect Molecular Mechanisms Underlying Methylene Blue-Glycosaminoglycan Interactions.
    Maszota-Zieleniak M; Zsila F; Samsonov SA
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
    Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
    Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy.
    Künze G; Köhling S; Vogel A; Rademann J; Huster D
    J Biol Chem; 2016 Feb; 291(6):3100-13. PubMed ID: 26677224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions.
    Robinson DE; Buttle DJ; Short RD; McArthur SL; Steele DA; Whittle JD
    Biomaterials; 2012 Feb; 33(4):1007-16. PubMed ID: 22079008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic degradation of glycosaminoglycans.
    Ernst S; Langer R; Cooney CL; Sasisekharan R
    Crit Rev Biochem Mol Biol; 1995; 30(5):387-444. PubMed ID: 8575190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Xylosides: Probing the Glycosaminoglycan Biosynthetic Machinery for Biomedical Applications.
    Chua JS; Kuberan B
    Acc Chem Res; 2017 Nov; 50(11):2693-2705. PubMed ID: 29058876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan-Protein Interactions: The First Draft of the Glycosaminoglycan Interactome.
    Vallet SD; Clerc O; Ricard-Blum S
    J Histochem Cytochem; 2021 Feb; 69(2):93-104. PubMed ID: 32757871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans (GAGs) and GAG mimetics regulate the behavior of stem cell differentiation.
    Wang M; Liu X; Lyu Z; Gu H; Li D; Chen H
    Colloids Surf B Biointerfaces; 2017 Feb; 150():175-182. PubMed ID: 27914254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturation Transfer Difference in Characterization of Glycosaminoglycan-Protein Interactions.
    Vignovich WP; Pomin VH
    SLAS Technol; 2020 Aug; 25(4):307-319. PubMed ID: 32452261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans.
    Penk A; Baumann L; Huster D; Samsonov SA
    Glycobiology; 2019 Sep; 29(10):715-725. PubMed ID: 31264681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Procollagen C-Proteinase Enhancer-1/Glycosaminoglycan Binding Sites and of the Potential Role of Calcium Ions in the Interaction.
    Potthoff J; Bojarski KK; Kohut G; Lipska AG; Liwo A; Kessler E; Ricard-Blum S; Samsonov SA
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAG-DB, the New Interface of the Three-Dimensional Landscape of Glycosaminoglycans.
    Pérez S; Bonnardel F; Lisacek F; Imberty A; Ricard Blum S; Makshakova O
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical application of glycosaminoglycans: a review.
    Köwitsch A; Zhou G; Groth T
    J Tissue Eng Regen Med; 2018 Jan; 12(1):e23-e41. PubMed ID: 28079984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycan-Protein Interactions by Nuclear Magnetic Resonance (NMR) Spectroscopy.
    Pomin VH; Wang X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30208595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans in cancer therapy.
    Wieboldt R; Läubli H
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1187-C1200. PubMed ID: 35385322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of glycosaminoglycan-protein interactions.
    Kjellén L; Lindahl U
    Curr Opin Struct Biol; 2018 Jun; 50():101-108. PubMed ID: 29455055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.